527(top 1%)
papers
25.3K(top 1%)
citations
84(top 0.1%)
h-index
135(top 1%)
g-index
569
all documents
26.7K
doc citations
3.2K
citing journals

Top Articles

#TitleJournalYearCitations
1IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapyNature Genetics20091,808
2Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failureHepatology2016550
3Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfectionLancet, The2003511
4Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up studyHepatology2010458
5A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosisNature Genetics2015435
6Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patientsGenome Medicine2017420
7Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing CholangitisGastroenterology2017355
8Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthaseHepatology2007276
9Itraconazole Prevents Invasive Fungal Infections in Neutropenic Patients Treated for Hematologic Malignancies: Evidence From a Meta-Analysis of 3,597 PatientsJournal of Clinical Oncology2003263
10Good long-term outcome of Budd-Chiari syndrome with a step-wise managementHepatology2013237
11Comparison of Capsule Endoscopy and Magnetic Resonance Imaging for the Detection of Polyps of the Small Intestine in Patients with Familial Adenomatous Polyposis or with Peutz-Jeghers’ SyndromeEndoscopy2004229
12Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic ratsHepatology2014224
13Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLFJournal of Hepatology2020223
14A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myelomaBritish Journal of Haematology2006218
15Functional Variants of the Central Bile Acid Sensor FXR Identified in Intrahepatic Cholestasis of PregnancyGastroenterology2007215
16Neutropenic enterocolitis in adults: systematic analysis of evidence qualityEuropean Journal of Haematology2005214
17Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cellsJournal of Hepatology2010197
18Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosisHepatology2004196
19Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical TherapyGastroenterology2015196
20Association between thePNPLA3(rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant dataHepatology2014193
21Bleeding Complications after Percutaneous Liver BiopsyDigestion2003187
22Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and CirrhosisGastroenterology2016186
23MDRD Equations for Estimation of GFR in Renal Transplant RecipientsAmerican Journal of Transplantation2005170
24FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosisScientific Reports2016168
25Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemiaLeukemia2004163
26Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With CirrhosisGastroenterology2018162
27Comparison of Meld, Child-Pugh, and Emory Model for The Prediction of Survival in Patients Undergoing Transjugular Intrahepatic Portosystemic ShuntingAmerican Journal of Gastroenterology2003156
28The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic RatsAmerican Journal of Pathology2015156
29Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver diseaseNature Communications2015156
30Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosisJournal of Hepatology2013154
31The HLA-A2 Restricted T Cell Epitope HCV Core35–44 Stabilizes HLA-E Expression and Inhibits Cytolysis Mediated by Natural Killer CellsAmerican Journal of Pathology2005149
32Porto-sinusoidal vascular disease: proposal and description of a novel entityThe Lancet Gastroenterology and Hepatology2019149
33Clostridium difficileInfection in Patients with NeutropeniaClinical Infectious Diseases2001147
34Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational StudyHepatology2019144
35Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosisHepatology2003143
36Allogeneic Dendritic Cells Fused with Tumor Cells: Preclinical Results and Outcome of a Clinical Phase I/II Trial in Patients with Metastatic Renal Cell CarcinomaHuman Gene Therapy2003141
37HIV-1 Infection Leads to Increased HLA-E Expression Resulting in Impaired Function of Natural Killer CellsAntiviral Therapy2005140
38Mechanisms of Disease: the genetic epidemiology of gallbladder stonesNature Reviews Gastroenterology & Hepatology2005138
39Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertensionGastroenterology2001137
40Mechanisms of extrahepatic vasodilation in portal hypertensionGut2008134
41Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated CirrhosisFrontiers in Immunology2019134
42NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent mannerLaboratory Investigation2012132
43Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting AntiviralsGastroenterology2018132
44Dependence of Oxalate Absorption on the Daily Calcium IntakeJournal of the American Society of Nephrology: JASN2004129
45Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 InductionPLoS ONE2011129
46Interferon-lambda serum levels in hepatitis CJournal of Hepatology2011128
47Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosisScientific Reports2015127
48Calculation of glomerular filtration rate based on Cystatin C in cirrhotic patientsNephrology Dialysis Transplantation2006125
49Natural killer p46Highexpression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosisHepatology2012122
50Transduction of Human PBMC-Derived Dendritic Cells and Macrophages by an HIV-1-Based Lentiviral Vector SystemMolecular Therapy2000120